Geburtsdatum
Alter
15.07.1992 (Alter: 31)
31
(15.07.1992)
Draft
Saison 14 / #23 (CLE)
Saison 14 / #23
(CLE)
Career Earnings
360.80 Mio
Gesamt
TOT
18
13105
7050
2290
1092
479
157
375
1821
1821
952
2227
566
652
403
630
1190
494
377
24
15
0
6331
Schnitt
AVG
26.5
14.3
4.6
2.2
1.0
0.3
0.8
3.7
7.0
1.9
4.5
1.1
1.3
0.8
1.3
2.4
52.9%
42.7%
86.8%
27.4
20.9
1.3
0.8
0.0
12.8
20.7%
17.9
2.9
0.76
0.25
Career High
High
36
55
12
8
4
5
5
12
24
15
22
8
10
5
6
39
Gesamt
TOT
10
1065
631
155
85
28
12
36
0
94
94
194
69
77
21
39
-61
39
21
0
1
0
549
Schnitt
AVG
27.3
16.2
4.0
2.2
0.7
0.3
0.9
3.6
7.3
2.4
5.0
1.8
2.0
0.5
1.0
-1.6
49.1%
48.5%
89.6%
3.9
2.1
0.0
0.1
0.0
14.1
0.0%
18.4
0.0
0.00
0.00
Career High
High
32
22
7
5
2
1
2
5
11
4
7
9
10
2
2
18
Gesamt
TOT
1176
622
231
139
42
17
42
219
395
46
109
50
71
46
63
235
42
42
4
1
0
577
Schnitt
AVG
28.0
14.8
5.5
3.3
1.0
0.4
1.0
5.2
9.4
1.1
2.6
1.2
1.7
1.1
1.5
5.6
55.4%
42.2%
70.4%
13.7
22.0%
18.9
3.31
0.67
0.27
Season High
High
33
31
10
7
3
2
4
11
18
4
6
4
6
4
5
30
87.5%
75.0%
75.0%
26
37.1%
38.8
7.00
2.00
1.00
38
83
CLE
11.0
29.2
8.8
3.8
1.5
1.2
0.1
0.6
1.8
3.7
1.5
3.9
0.7
0.8
0.4
1.2
0.4
49.3%
37.8%
87.5%
19
19
0
0
0
8.6
13.6%
10.3
2.55
1.05
0.09
37
81
IND
26.0
28.2
10.2
3.8
1.9
1.0
0.0
0.9
2.5
3.9
1.5
3.2
0.5
0.7
1.0
1.2
-2.4
64.7%
48.2%
82.4%
26
24
1
0
0
8.3
12.9%
13.9
2.17
0.90
0.00
36
82
IND
26.0
26.4
21.9
4.3
1.7
0.5
0.1
0.5
4.5
9.0
3.1
6.4
3.4
3.7
0.9
1.7
1.3
50.2%
49.1%
93.0%
27
27
1
1
0
17.6
28.5%
25.0
3.29
0.28
0.06
35
82
IND
26.0
21.9
9.2
3.6
2.0
0.9
0.0
1.0
2.2
4.6
1.2
3.0
1.1
1.5
0.6
0.8
5.1
49.2%
40.7%
76.7%
29
0
2
0
0
9.1
17.9%
13.7
2.04
1.04
0.00
34
85
TOR
26.0
25.6
17.8
4.0
2.5
0.9
0.4
0.9
4.7
8.6
2.5
4.8
0.9
1.0
0.6
0.8
-1.8
54.1%
52.6%
88.9%
28
10
3
0
0
14.8
26.4%
22.9
2.76
1.09
0.43
33
85
TOR
26.0
26.8
14.0
4.2
1.8
0.8
0.2
0.6
3.9
8.0
1.9
4.8
0.4
0.4
1.0
0.7
1.9
48.5%
39.7%
100.0%
25
26
2
0
0
13.7
23.1%
15.4
2.88
1.12
0.29
32
85
LAC
25.0
25.8
23.9
3.4
1.8
0.7
0.4
0.8
3.7
6.2
5.0
8.4
1.6
1.6
0.4
1.3
16.2
59.4%
59.8%
97.5%
25
25
2
0
0
16.1
27.0%
30.8
2.30
0.52
0.27
31
84
POR
25.0
29.5
14.9
4.1
2.7
1.0
0.1
0.7
4.5
7.9
1.5
4.5
1.4
1.4
0.8
1.5
-0.8
57.0%
32.8%
97.4%
27
27
2
0
0
13.8
20.0%
16.1
3.65
0.68
0.10
30
85
DAL
25.0
27.6
16.5
5.5
2.5
1.0
0.5
1.0
4.5
8.5
2.2
6.1
1.0
1.3
0.9
1.5
-1.3
52.3%
36.1%
78.8%
26
27
2
2
0
16.1
26.0%
18.0
2.60
0.66
0.32
29
85
MIL
25.0
27.9
18.0
6.5
2.5
1.0
0.3
0.7
3.8
7.8
3.1
7.8
1.1
1.2
1.0
1.5
2.3
49.0%
39.4%
90.9%
45
45
3
5
0
16.8
22.0%
20.1
3.50
0.71
0.23
28
86
BOS
25.0
26.1
15.8
4.7
1.5
0.9
0.8
0.6
3.6
6.2
2.7
6.4
0.7
0.8
0.4
1.3
7.9
58.1%
42.2%
87.5%
40
39
2
0
0
13.6
24.0%
19.8
2.50
0.69
0.62
27
82
ORL
12.0
28.0
14.8
5.5
3.3
1.0
0.4
1.0
5.2
9.4
1.1
2.6
1.2
1.7
1.1
1.5
5.6
55.4%
42.2%
70.4%
42
42
4
1
0
13.7
22.0%
18.9
3.31
0.67
0.27
26
82
ORL
12.0
30.1
18.4
5.7
3.1
1.5
0.5
1.1
5.6
10.8
1.7
3.7
2.1
2.3
1.6
1.8
1.0
51.8%
45.9%
90.8%
33
0
0
4
0
16.6
24.0%
21.3
2.83
0.85
0.29
25
78
ORL
12.0
26.2
8.0
5.4
3.2
1.0
0.4
0.7
3.2
5.9
0.2
1.1
1.0
1.3
1.0
1.4
-1.2
54.2%
17.2%
76.5%
26
28
0
0
0
8.3
9.0%
13.4
4.61
0.72
0.28
24
80
SAC
12.0
28.9
10.7
5.7
2.0
1.4
0.4
0.6
3.8
7.2
0.5
1.9
1.6
1.7
1.1
1.1
1.7
52.8%
27.6%
92.3%
15
0
0
1
0
10.5
13.0%
14.5
3.33
1.24
0.35
23
78
CLE
15.4
14.5
5.2
1.8
0.5
0.5
0.3
0.2
1.3
2.2
0.7
1.3
0.5
0.7
0.3
1.3
-1.5
61.5%
50.0%
75.0%
6
0
0
0
0
4.0
1.0%
13.1
3.00
0.38
0.25
21
79
DEN
8.0
20.0
4.9
2.2
1.7
0.7
0.3
0.7
1.2
3.4
0.7
3.3
0.4
0.5
0.2
0.9
-4.0
34.7%
22.0%
78.6%
28
11
0
0
0
7.5
0.0%
5.1
2.53
0.76
0.28
20
80
GSW
8.0
25.7
10.1
5.3
1.3
1.3
0.2
0.4
2.8
5.3
1.4
2.6
0.5
0.5
0.8
1.1
5.6
52.4%
53.6%
92.9%
27
27
0
1
0
8.5
0.0%
15.5
2.92
1.13
0.20
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-06-10
06-10
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2022-05-23
05-23
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2022-05-23
05-23
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-22
05-22
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-15
05-15
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-09
05-09
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-05-01
05-01
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-30
04-30
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-24
04-24
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-17
04-17
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-10
04-10
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-09
04-09
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-07
04-07
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-03
04-03
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-04-02
04-02
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-27
03-27
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-26
03-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-25
03-25
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-21
03-21
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-20
03-20
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-03-19
03-19
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-14
01-14
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2022-01-12
01-12
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2022-01-12
01-12
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2022-01-03
01-03
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-26
12-26
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-12-23
12-23
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-27
11-27
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-13
11-13
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-09
11-09
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-11-08
11-08
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2021-10-31
10-31
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2021-10-31
10-31
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2021-10-30
10-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2021-10-30
10-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-30
10-30
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-23
10-23
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-21
10-21
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-18
10-18
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-14
10-14
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-13
10-13
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-12
10-12
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-10
10-10
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-09
10-09
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-06
10-06
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-05
10-05
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-04
10-04
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-03
10-03
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2021-10-02
10-02
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2019-02-03
02-03
ORL
BKN
23
6
3
1
1
0
1
3
8
0
0
0
0
1
1
21
37.5%
--
--
x
9
0.0%
5.4
1.00
1.00
0.00
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
BKN
29
15
7
3
1
0
0
6
11
1
3
0
0
1
0
3
50.0%
33.3%
--
x
14
23.8%
19.1
--
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-03
02-03
ORL
MEM
30
9
2
7
1
1
1
3
5
1
3
0
0
0
0
11
50.0%
33.3%
--
x
9
14.0%
15.3
7.00
--
--
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
PHX
31
12
7
2
1
1
4
4
10
1
2
1
2
2
4
13
41.7%
50.0%
50.0%
x
17
28.1%
7.1
0.50
0.25
0.25
2019-02-02
02-02
ORL
NYK
30
20
2
0
0
0
0
4
4
4
6
0
0
0
0
-7
80.0%
66.7%
--
x
10
14.9%
23.5
--
--
--
2019-02-01
02-01
ORL
TOR
31
19
6
3
1
0
1
6
12
1
1
4
4
4
2
-6
53.8%
100.0%
100.0%
x
16
19.7%
23.2
3.00
0.50
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-02-01
02-01
ORL
MIN
27
9
9
2
0
0
1
3
6
1
1
0
0
1
1
-13
57.1%
100.0%
--
x
8
13.4%
13.4
2.00
0.00
0.00
2019-01-30
01-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2019-01-30
01-30
ORL
SAS
30
24
6
4
3
1
3
9
13
2
4
0
0
2
4
19
64.7%
50.0%
--
x
x
20
30.1%
29.4
1.33
0.75
0.25
2019-01-30
01-30
ORL
MIL
31
17
9
6
1
0
1
7
12
1
3
0
0
1
1
15
53.3%
33.3%
--
x
16
22.0%
21.8
6.00
1.00
0.00
2019-01-27
01-27
ORL
ATL
29
13
5
3
0
0
2
5
12
1
4
0
0
1
0
8
37.5%
25.0%
--
x
18
25.8%
7.7
1.50
--
--
2019-01-27
01-27
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2019-01-27
01-27
ORL
HOU
28
12
3
3
0
0
1
5
8
0
1
2
2
0
1
10
55.6%
0.0%
100.0%
x
11
16.4%
13.2
3.00
0.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIL
21
21
4
4
2
0
0
8
10
1
5
2
2
1
2
15
60.0%
20.0%
100.0%
x
16
32.5%
38.8
--
1.00
0.00
2019-01-12
01-12
ORL
MIA
25
16
4
3
2
0
0
5
8
2
3
0
0
0
0
17
63.6%
66.7%
--
x
11
22.5%
27.3
--
--
--
2019-01-11
01-11
ORL
PHI
29
16
8
4
0
0
0
5
6
2
2
0
0
0
1
17
87.5%
100.0%
--
x
8
12.5%
26.0
--
0.00
0.00
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-11
01-11
ORL
OKC
27
10
6
3
1
1
0
3
5
1
4
1
1
0
0
-4
44.4%
25.0%
100.0%
x
9
14.8%
16.4
--
--
--
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
UTA
23
19
6
5
0
0
1
4
8
3
4
2
2
0
2
15
58.3%
75.0%
100.0%
x
14
24.7%
30.0
5.00
0.00
0.00
2019-01-06
01-06
ORL
CLE
23
15
2
3
0
0
1
4
8
1
3
4
4
1
1
21
45.5%
33.3%
100.0%
x
14
28.5%
18.9
3.00
0.00
0.00
2018-12-21
12-21
ORL
WAS
33
12
6
2
2
2
2
6
14
0
3
0
0
0
3
-6
35.3%
0.0%
--
x
19
24.1%
6.8
1.00
0.67
0.67
2018-12-13
12-13
ORL
DET
30
10
5
4
3
0
1
2
3
1
5
3
4
0
5
3
37.5%
20.0%
75.0%
x
11
16.0%
13.0
4.00
0.60
0.00
2018-12-10
12-10
ORL
IND
27
13
5
3
0
1
1
5
13
1
3
0
0
4
3
-11
37.5%
33.3%
--
x
17
29.7%
11.9
3.00
0.00
0.33
2018-12-10
12-10
ORL
IND
27
13
5
3
0
1
1
5
13
1
3
0
0
4
3
-11
37.5%
33.3%
--
x
17
29.7%
11.9
3.00
0.00
0.33
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-08
12-08
ORL
SAC
32
31
4
5
1
0
1
11
18
2
4
3
6
1
1
-7
59.1%
50.0%
50.0%
x
x
26
37.1%
30.9
5.00
1.00
0.00
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-07
12-07
ORL
DET
30
30
6
3
2
1
2
9
12
3
4
3
3
0
2
2
75.0%
75.0%
100.0%
x
19
26.4%
38.0
1.50
1.00
0.50
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
MIA
21
17
3
2
0
0
0
4
6
2
2
3
4
0
0
26
75.0%
100.0%
75.0%
x
x
10
23.9%
30.7
--
--
--
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-12-01
12-01
ORL
LAL
31
2
4
4
2
0
2
1
3
0
1
0
0
1
2
-14
25.0%
0.0%
--
x
6
8.0%
4.2
2.00
1.00
0.00
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-30
11-30
ORL
WAS
31
12
7
5
2
0
0
6
11
0
1
0
0
2
0
-9
50.0%
0.0%
--
x
12
15.8%
19.2
--
--
--
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-28
11-28
ORL
PHI
28
14
8
3
1
0
1
4
7
2
3
0
0
3
1
-8
60.0%
66.7%
--
x
11
17.1%
22.0
3.00
1.00
0.00
2018-11-26
11-26
ORL
CHA
29
13
6
4
1
0
1
5
7
1
1
0
0
1
1
16
75.0%
100.0%
--
x
9
12.6%
20.8
4.00
1.00
0.00
2018-11-25
11-25
ORL
CHI
32
15
9
2
1
1
0
6
10
1
3
0
0
4
0
1
53.8%
33.3%
--
x
13
18.2%
21.1
--
--
--
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-24
11-24
ORL
IND
32
10
6
6
3
0
0
4
7
0
0
2
2
1
2
14
57.1%
--
100.0%
x
8
11.0%
20.0
--
1.50
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-21
11-21
ORL
BOS
27
15
8
4
2
0
1
7
12
0
0
1
1
0
1
30
58.3%
--
100.0%
x
13
22.6%
23.0
4.00
2.00
0.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-20
11-20
ORL
TOR
30
18
10
2
0
1
2
8
17
0
2
2
2
2
1
7
42.1%
0.0%
100.0%
x
22
31.3%
14.7
1.00
0.00
1.00
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-11
11-11
ORL
DAL
25
24
4
4
3
1
2
6
10
4
6
0
1
1
3
12
62.5%
66.7%
0.0%
x
x
18
30.0%
35.8
2.00
1.00
0.33
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-10
11-10
ORL
CHI
28
12
7
3
0
1
1
6
11
0
1
0
0
2
1
-1
50.0%
0.0%
--
x
13
20.7%
15.0
3.00
0.00
1.00
2018-11-07
11-07
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2018-11-07
11-07
ORL
LAC
29
17
2
2
1
1
2
7
12
0
3
3
4
1
1
-12
46.7%
0.0%
75.0%
x
19
26.8%
14.4
1.00
1.00
1.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-05
11-05
ORL
ATL
25
9
5
2
0
0
3
1
4
2
2
1
2
1
4
-1
50.0%
100.0%
50.0%
x
10
16.5%
6.9
0.67
0.00
0.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-11-02
11-02
ORL
DEN
26
18
8
4
1
1
0
8
12
0
2
2
4
2
1
21
57.1%
0.0%
50.0%
x
16
29.5%
28.4
--
1.00
1.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
NYK
23
17
7
5
0
0
2
5
11
1
3
4
6
2
1
12
42.9%
33.3%
66.7%
x
19
36.9%
21.8
2.50
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-31
10-31
ORL
GSW
30
18
4
2
0
0
0
8
13
0
1
2
2
2
4
-6
57.1%
0.0%
100.0%
x
15
20.8%
18.2
--
0.00
0.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-28
10-28
ORL
CLE
29
16
6
3
2
1
0
5
10
1
3
3
6
0
1
-7
46.2%
33.3%
50.0%
x
16
23.6%
20.0
--
2.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-24
10-24
ORL
NOP
27
8
4
4
0
1
1
2
10
1
4
1
3
0
1
-5
21.4%
25.0%
33.3%
x
16
26.4%
1.6
4.00
0.00
1.00
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2018-10-14
10-14
ORL
POR
25
12
2
1
2
2
0
4
6
1
3
1
1
1
0
24
55.6%
33.3%
100.0%
x
9
15.0%
21.5
--
--
--
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00
2008-10-16
10-16
ORL
CHA
28
7
5
3
0
0
2
3
7
0
2
1
2
2
2
-1
33.3%
0.0%
50.0%
x
12
16.4%
4.0
1.50
0.00
0.00